Preservation of transendothelial glucose transporter 1 and P-glycoprotein transporters in a cortical slice culture model of the blood-brain barrier

Neuroscience

Volumn 170, Issue 1, 2010, Pages 361-371

  Camenzind, R S ^a   Chip, S ^a   Gutmann, H ^b   Kapfhammer, J P ^a   Nitsch, C ^a   Bendfeldt, K ^c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Brain vasculature; Cortical organotypic slice cultures; Endothelial cells; Glucose transporter 1; Mouse; P glycoprotein

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GLUCOSE TRANSPORTER 1; GLYCOPROTEIN P; RHODAMINE 123; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN CORTEX; CONTROLLED STUDY; IN VITRO STUDY; MEMBRANE TRANSPORT; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE CULTURE; TISSUE PRESERVATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANIMALS, NEWBORN; BLOOD-BRAIN BARRIER; CEREBRAL CORTEX; ENDOTHELIAL CELLS; GLUCOSE TRANSPORTER TYPE 1; MICE; MICE, INBRED C57BL; ORGAN CULTURE TECHNIQUES; P-GLYCOPROTEIN;

EID: 77955918251     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.073     Document Type: Article

References (51)

1. Abbott N.J. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 2002, 200:629-638.
2. Abbott N.J., Romero I.A. Transporting therapeutics across the blood-brain barrier. Mol Med Today 1996, 2:106-113.
3. Bauer B., Hartz A.M.S., Fricker G., Miller D.S. Pregnane X receptor up-regulation of p-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 2004, 66:413-419.
4. Bauer B., Hartz A.M., Fricker G., Miller D.S. Modulation of p-glycoprotein transport function at the blood-brain barrier. Exp Biol Med (Maywood) 2005, 230:118-127.
5. Bauer B., Hartz A.M.S., Pekcec A., Toellner K., Miller D.S., Potschka H. Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Mol Pharmacol 2008, 73:1444-1453.
6. Beaulieu E., Demeule M., Ghitescu L., Beaulieu R. P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem J 1997, 326:539-544.
7. Begley D.J., Brightman M.W. Structural and functional aspects of the blood-brain barrier. Prog Drug Res 2003, 61:39-78.
8. Bendayan R., Lee G., Bendayan M. Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc Res Tech 2002, 57:365-380.
9. Bendfeldt K., Radojevic V., Kapfhammer J., Nitsch C. Basic fibroblast growth factor modulates density of blood vessels and preserves tight junctions in organotypic cortical cultures of mice: a new in vitro model of the blood-brain barrier. J Neurosci 2007, 27:3260-3267.
10. Bogman K., Peyer A., Török M., Küsters E., Drewe J. HMG-CoA reductase inhibitors and P-glycoprotein modulation. Br J Pharmacol 2001, 132:1183-1192.
11. Cecchelli R., Dehouck B., Descamps L., Fenart L., Buée-Scherrer V., Duhem C., Lundquist S., Rentfel M., Torpier G., Dehouck M.P. In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev 1999, 36:165-178.
12. Cirrito J.R., Deane R., Fagan A.M., Spinner M.L., Parsadanian M., Finn M.B., Jiang H., Prior J.L., Sagare A., Bales K.R., Paul S.M., Zlokovic B.V., Piwnica-Worms D., Holtzman D.M. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model. J Clin Invest 2005, 115:3285-3290.
13. Colgan O.C., Collins N.T., Ferguson G., Murphy R.P., Birney Y.A., Cahill P.A., Cummins P.M. Influence of basolateral condition on the regulation of brain microvascular endothelial tight junction properties and barrier function. Brain Res 2008, 1193:84-92.
14. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer L., Biedler J.L., Melamed M.R., Bertino J.R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A 1989, 86:695-698.
15. Deeley R.G., Westlake C., Cole S.P. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 2006, 86:849-899.
16. Dermietzel R., Krause D., Kremer M., Wang C., Stevenson B. Pattern of glucose transporter (Glut 1) expression in embryonic brains is related to maturation of blood-brain barrier tightness. Dev Dyn 1992, 193:152-163.
17. Dick A.P., Harik S.I., Klip A., Walker D.M. Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity. Proc Natl Acad Sci U S A 1984, 81:7233-7237.
18. Fontaine M., Elmquist W.F., Miller D.W. Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. Life Sci 1996, 59:1521-1531.
19. Garbuzova-Davis S., Saporta S., Haller E., Kolomey I., Bennett S.P., Potter H., Sanberg P.R. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One 2007, 2:e1205.
20. Girardin F. Membrane transporter proteins: a challenge for CNS drug development. Dialogues Clin Neurosci 2006, 8:311-321.
21. Golden P., Kang J., Bickel U. Brain microvascular and astrocyte localization of P-glycoprotein. J Neurochem 1997, 68:1278-1285.
22. Guo X., Geng M., Du G. Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier. Biochem Genet 2005, 43:175-187.
23. Gutmann H., Torok M., Fricker G., Huwyler J., Beglinger C., Drewe J. Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro. Drug Metab Dispos 1999, 27:937-941.
24. Hauw J.J., Berger B., Escourolle R. Ultrastructural observations on human cerebral capillaries in organ culture. Cell Tissue Res 1975, 163:133-150.
25. Hegmann E.J., Bauer H.C., Kerbel R.S. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res 1992, 52:6969-6975.
26. Huwyler J., Drewe J., Klusemann C., Fricker G. Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium. Br J Pharmacol 1996, 118:1879-1885.
27. Jette L., Tetu B., Beliveau R. High levels of P-glycoprotein detected in isolated brain capillaries. Biochim Biophys Acta 1993, 1150:147-154.
28. Lin J.H., Yamazaki M. Clinical relevance of P-glycoprotein in drug therapy. Drug Metab Rev 2003, 35:417-454.
29. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 1997, 40(Suppl):S3-S8.
30. Mealey K.L. Therapeutic implications of the MDR-1 gene. J Vet Pharmacol Ther 2004, 27:257-264.
31. Miller D.S., Bauer B., Hartz A.M.S. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev 2008, 60:196-209.
32. Miller D.S., Nobmann S.N., Gutmann H., Toeroek M., Drewe J., Fricker G. Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharmacol 2000, 58:1357-1367.
33. Moser K.V., Schmidt-Kastner R., Hinterhuber H., Humpel C. Brain capillaries and cholinergic neurons persist in organotypic brain slices in the absence of blood flow. Eur J Neurosci 2003, 18:85-94.
34. Poller B., Drewe J., Krahenbuhl S., Huwyler J., Gutmann H. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier. Cell Mol Neurobiol 2010, 30:63-70.
35. Radojevic V., Kapfhammer J.P. Repair of the entorhino-hippocampal projection in vitro. Exp Neurol 2004, 188:11-19.
36. Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A., Borst P. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 1995, 96:1698-1705.
37. Schumacher U., Mollgård K. The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain. Histochem Cell Biol 1997, 108:179-182.
38. Seeta S., Lynn M., Rik J.S. Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates. J Neurochem 1998, 70:1151-1159.
39. Siesjo B.K. Brain energy metabolism and catecholaminergic activity in hypoxia, hypercapnia and ischemia. J Neural Transm Suppl 1978, 1:17-22.
40. Simpson I.A., Carruthers A., Vannucci S.J. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab 2007, 27:1766-1791.
41. Stoppini L., Buchs P.A., Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991, 37:173-182.
42. Sugawara I., Hamada H., Tsuruo T., Mori S. Specialized localization of P-glycoprotein recognized by MRK 16 monoclonal antibody in endothelial cells of the brain and the spinal cord. Jpn J Cancer Res 1990, 81:727-730.
43. Tatsuta T., Naito M., Oh-hara T., Sugawara I., Tsuruo T. Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem 1992, 267:20383-20391.
44. Taylor E.M. The impact of efflux transporters in the brain on the development of drugs for CNS disorders. Clin Pharmacokinet 2002, 41:81-92.
45. Tomkins O., Friedman O., Ivens S., Reiffurth C., Major S., Dreier J.P., Heinemann U., Friedman A. Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol Dis 2007, 25(2):367-377.
46. Török M., Huwyler J., Gutmann H., Fricker G., Drewe J. Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions. Exp Brain Res 2003, 153:356-365.
47. Tsai C.E., Daood M.J., Lane R.H., Hansen T.W., Gruetzmacher E.M., Watchko J.F. P-glycoprotein expression in mouse brain increases with maturation. Biol Neonate 2002, 81:58-64.
48. Vannucci S.J., Clark R.R., Koehler-Stec E., Li K., Smith C.B., Davies P., Maher F., Simpson I.A. Glucose transporter expression in brain: relationship to cerebral glucose utilization. Dev Neurosci 1998, 20:369-379.
49. Wolff J.R., Rajan K.T., Noack W. The fate and fine structure of fragments of blood vessels in CNS tissue cultures. Cell Tissue Res 1974, 156:89-102.
50. Yasuji M., Mitsuhiro O., Yoshihisa K., Takashi T. Developmental expression of p-glycoprotein (multidrug resistance gene product) in the rat brain. J Neurobiol 1999, 39:383-392.
51. Ying Q., Thomas N.S. Mouse multidrug resistance 1a/3 gene is the earliest known endothelial cell differentiation marker during blood-brain barrier development. Dev Dyn 1995, 202:172-180.